Results 61 to 70 of about 61,893 (290)
We evaluated the in vitro activity of rifamycin derivatives, including rifampin, rifapentine, rifaximin, and rifabutin, against clinical nontuberculous mycobacteria (NTM) isolates.
Dae Hun Kim +5 more
semanticscholar +1 more source
An immunocompromised dialysis patient with skin and bone lesions [PDF]
Patients with chronic kidney failure have disturbances of immune function involving both innate and adaptive systems. These result in both immunodepression which increases susceptibility to infection and immunoactivation leading to a chronic inflammatory
Brown +7 more
core +2 more sources
Growing from common ground: nontuberculous mycobacteria and bronchiectasis
Bronchiectasis and nontuberculous mycobacteria (NTM) are intricately intertwined, with NTM capable of being both a cause and consequence of bronchiectatic disease.
E. Van Braeckel, C. Bosteels
semanticscholar +1 more source
Antimycobacterial Activity of Laurinterol and Aplysin from Laurencia johnstonii
Marine environments represent a great opportunity for the discovery of compounds with a wide spectrum of bioactive properties. Due to their large variety and functions derived from natural selection, marine natural products may allow the identification ...
Sara García-Davis +7 more
doaj +1 more source
Occurrence of nontuberculous mycobacteria in aquatic sources of Sri Lanka [PDF]
Nontuberculous mycobacteria (NTM) have been reported to cause opportunistic infections with increasing frequency, especially in immunocompromised patients.
Bland +20 more
core +2 more sources
Pulmonary diseases caused by nontuberculous mycobacteria are increasingly becoming common worldwide and are occurring more frequently alongside pulmonary tuberculosis. Given that pulmonary diseases resulting from nontuberculous mycobacteria and pulmonary
Lyudmila Severova +14 more
doaj +1 more source
Probable disseminated Mycobacterium abscessus subspecies bolletii infection in a patient with idiopathic CD4+ T lymphocytopenia: a case report. [PDF]
INTRODUCTION: Rapidly growing mycobacteria are opportunistic pathogens in patients with underlying riskfactors. Mycobacterium abscessus subsp. bolletii is a newly recognized member of rapidlygrowing mycobacteria, isolated from respiratory tract and ...
BONURA, Celestino +7 more
core +2 more sources
Environmental mycobacteria – Future directions
Understanding environmental mycobacteria and the diseases they cause is woefully lacking. The number of species, their ubiquity in nature and the heterogeneity of their effects on their human hosts have made this a formidable task. Diagnosis is difficult.
D E Schraufnagel
doaj +1 more source
Autofluorescence as a tool for structural analysis of biofilms formed by nonpigmented rapidly growing mycobacteria [PDF]
The structure of biofilms formed by seven nonpigmented rapidly growing mycobacteria, including saprophytes and opportunistic species, was analyzed.
Estebana, Jaime +4 more
core +2 more sources
Antimicrobial peptide (AMP)‐loaded nanocarriers provide a multifunctional strategy to combat drug‐resistant Mycobacterium tuberculosis. By enhancing intracellular delivery, bypassing efflux pumps, and disrupting bacterial membranes, this platform restores phagolysosome fusion and macrophage function.
Christian S. Carnero Canales +11 more
wiley +1 more source

